Cargando…
Real‐time feedback control of voice in cochlear implant recipients
OBJECTIVES: To evaluate feedback‐dependent vocal control in cochlear implant patients using pitch‐shifted auditory feedback. METHODS: Twenty‐three CI recipients with at least 6 months of implant experience were enrolled. Vocal recordings were performed while subjects repeated the vowel /e/ and vocal...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752050/ https://www.ncbi.nlm.nih.gov/pubmed/33364407 http://dx.doi.org/10.1002/lio2.481 |
Sumario: | OBJECTIVES: To evaluate feedback‐dependent vocal control in cochlear implant patients using pitch‐shifted auditory feedback. METHODS: Twenty‐three CI recipients with at least 6 months of implant experience were enrolled. Vocal recordings were performed while subjects repeated the vowel /e/ and vocal signals were altered in real‐time using a digital effects processor to introduce a pitch‐shift, presented back to subjects using headphones. Recordings were analyzed to determine pitch changes following the pitch‐shifted feedback, and results compared to the magnitude of the shift as well as patient demographics. RESULTS: Consistent with previous results, CI patients' voices had higher pitches with their implant turned off, a change explainable by increases in vocal loudness without the CI. CI patients rapidly compensated for pitch‐shifted feedback by changing their vocal pitch, but only for larger shifts. Considerable inter‐subject variability was present, and weakly correlated with the duration of implant experience and implant sound thresholds. CONCLUSIONS: CI patients, like normal hearing individuals, are capable of real‐time feedback‐dependent control of their vocal pitch. However, CI patients are less sensitive to small feedback changes, possibly a result of courser CI frequency precision, and may explain poorer than normal vocal control in these patients. LEVEL OF EVIDENCE: Level 3b. |
---|